vimarsana.com

Page 4 - ஆர்டிநரீ பங்குதாரர் சந்தித்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SEIF S p A: SEIF - THE BOARD OF DIRECTORS CONVENES THE SHAREHOLDERS MEETING TO APPROVE THE AMENDMENTS TO THE BYLAWS AND THE PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY SHARES

SEIF S.p.A: SEIF - THE BOARD OF DIRECTORS CONVENES THE SHAREHOLDERS MEETING TO APPROVE THE AMENDMENTS TO THE BYLAWS AND THE PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY SHARES SOCIETÀ EDITORIALE IL FATTO S.P.A. THE BOARD OF DIRECTORS CONVENES THE SHAREHOLDERS MEETING TO APPROVE THE AMENDMENTS TO THE BYLAWS AND THE PROPOSAL TO AUTHORISE THE PURCHASE AND DISPOSAL OF TREASURY SHARES Rome, 24 February 2021 - Società Editoriale il Fatto S.p.A. ( Società o SEIF ), media content provider and publisher of several editorial and multimedial products, company whose shares are traded both on AIM Italia, a multilateral trading system organized and managed by Borsa Italiana S.p.A. and on

EDF:Mobilisation and solidarity during the health crisis; Acceleration of Renewables 2030 target upgraded ; 2020: Resilient EBITDA, 2020-2022 action plan on cost reduction and disposals undertaken ; 2021-2022: Financial targets confirm

EDF:Mobilisation and solidarity during the health crisis; Acceleration of Renewables 2030 target upgraded ; 2020: Resilient EBITDA, 2020-2022 action plan on cost reduction and disposals undertaken ; 2021-2022: Financial targets confirm
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

GOL announces information about the Corporate Reorganization

GOL announces information about the Corporate Reorganization USA - English Share this article SAO PAULO, Feb. 12, 2021 /PRNewswire/   GOL Linhas Aéreas Inteligentes S.A. ( GOL ) (NYSE: GOL and B3: GOLL4), Brazil s #1 domestic airline, pursuant to paragraph 4 of Article 157 of Law No. 6,404, dated December 15, 1976, as amended  ( Brazilian Corporate Law ), CVM Instruction No. 358/2002 ( ICVM 358 ) and CVM Instruction No. 565/2014  ( ICVM 565 ), hereby inform that, on the date hereof, a shareholders meeting has been called to pass a resolution on the corporate reorganization (disclosed in GOL s material facts dated December 7, 2020 and January 18, 2021), as detailed below  ( Reorganization ). 1.1. (a)  Identification. GOL Linhas Aéreas Inteligentes S.A., a publicly-held company headquartered in the city of São Paulo, state of São Paulo, at Praça Comandante Lineu Gomes, S/N, Portaria 3, Jardim Aeroporto, 04626-020, enrolled with the Corporate Taxpayers Regis

RUBIS: Presentation of the share buyback program authorized by the Combined Shareholders Meeting held on Dec 9, 2020

(2) DJ RUBIS: Presentation of the share buyback program authorized by the Combined Shareholders Meeting held on Dec. 9, 2020 RUBIS RUBIS: Presentation of the share buyback program authorized by the Combined Shareholders Meeting held on Dec. 9, 2020 23-Dec-2020 / 19:00 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Paris, December 23, 2020, 7:00 pm This presentation of the share buyback program is set in accordance with the provisions of articles 241-1 and 241-2 of the General Regulation of the Autorité des Marchés Financiers (AMF). It aims at disclosing the objectives and the modalities of the buyback program by the Company of its own shares,

MedinCell: Live Webcast of the Shareholders Meeting on Tuesday, December 15, 2020

MedinCell: Live Webcast of the Shareholders Meeting on Tuesday, December 15, 2020 MedinCell (Paris:MEDCL): The Ordinary Shareholders Meeting will be held in a closed session on Tuesday, December 15, 2020 at 5:00 p.m. CET. A live webcast of the event will be available on the Company s website: https://invest.medincell.com/agconference/ Shareholders are called to approve the appointment of Elisabeth Kogan to the Supervisory Board of MedinCell. Access the terms and conditions for participating and voting by mail or proxy: press release of November 9, 2020. About MedinCell MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.